ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19GlobeNewsWire • 12/02/21
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/02/21
ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue UnchangedBenzinga • 10/29/21
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety DataGlobeNewsWire • 10/28/21
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19GlobeNewsWire • 09/16/21
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/04/21
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19GlobeNewsWire • 07/13/21
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13thGlobeNewsWire • 07/09/21
ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/11/21
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial OfficerGlobeNewsWire • 05/03/21
ARCA biopharma Announces 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/18/21
ARCA biopharma Announces Location Change for 2020 Annual Meeting of StockholdersGlobeNewsWire • 12/09/20
ARCA Biopharma gets Fast Track designation for experimental COVID-19 treatmentMarket Watch • 11/23/20
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track DesignationGlobeNewsWire • 11/23/20
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/02/20
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19GlobeNewsWire • 10/07/20
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & QualityGlobeNewsWire • 10/05/20
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19GlobeNewsWire • 09/21/20
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/05/20